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Summary Statement: Insulin-like growth factor signaling plays a critical role in regulating 
entrance into embryonic diapause and may determine many of the complex life history 
characteristics unique to annual killifishes. 
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Abstract 
Annual killifishes exhibit a number of unique life history characters including the 
occurrence of embryonic diapause, unique cell movements associated with dispersion and 
subsequent reaggregation of the embryonic blastomeres, and a short post-embryonic life 
span. Insulin-like growth factor (IGF) signaling is known to play a role in the regulation of 
metabolic dormancy in a number of animals but has not been explored in annual killifishes. 
The abundance of IGF proteins during development, and the developmental effects of 
blocking IGF signaling by pharmacological inhibition of the insulin-like growth factor I receptor 
(IGF1R) were explored in embryos of the annual killifish Austrofundulus limnaeus. Blocking of 
IGF signaling in embryos that would normally escape entrance into diapause resulted in a 
phenotype that was remarkably similar to embryos entering diapause. IGF-I protein 
abundance spikes during early development in embryos that will not enter diapause. In 
contrast, IGF-I levels remain low during early development in embryos that will enter 
diapause II. IGF-II protein levels are packaged at higher levels in escape-bound embryos 
compared to diapause-bound embryos. However, IGF-II levels quickly decrease and remain 
low during early development and only increase substantially during late development in both 
developmental trajectories. Developmental patterns of IGF-I and IGF-II protein abundance 
under conditions that would either induce or bypass entrance into diapause are consistent 
with a role for IGF signaling in the regulation of developmental trajectory and entrance into 
diapause in this species. We propose that IGF signaling may be a unifying regulatory pathway 
that explains the larger suite of characters that are associated with the complex life history of 
annual killifishes.  
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Introduction 
 
The cellular mechanisms that support entrance into reversible states of metabolic and 
developmental arrest have been studied across a wide range of organisms. There is 
considerable evidence accumulating that decreases in insulin-like growth factor (IGF) 
signaling pathways are of central importance for induction of dormancy and expression of 
multiple aspects of the dormant phenotype including shifts in metabolic rate and substrate 
utilization, reduced cell proliferation, and protection from environmental stresses such as 
anoxia or starvation (Lin et al., 2001; Puig et al., 2003; Sim and Denlinger, 2008; Sim et al., 
2015). The critically important and highly conserved role of IGFs in supporting cellular growth 
and proliferation suggests that downregulation of IGF signaling may be a critical and perhaps 
universal aspect of entrance into metabolic and developmental arrest. This paper explores 
the role of IGF signaling in the regulation of developmental and metabolic arrest associated 
with embryonic diapause in embryos of the annual killifish Austrofundulus limnaeus. 
The annual killifish, Austrofundulus limnaeus, inhabits ephemeral ponds in Venezuela 
that dry on a seasonal basis (Hrbek et al., 2005; Podrabsky and Hand, 1999; Podrabsky et al., 
1998). This harsh and often unpredictable environment has driven the evolution of multiple 
adaptations for survival in temporary aquatic habitats, the most crucial of which is the ability 
to arrest development in diapause to support survival through the dry season (Myers, 1952; 
Peters, 1963; Wourms, 1972a; Wourms, 1972b). Embryos may arrest development in up to 
three stages of diapause, termed diapause I, II, and III (Wourms, 1972a; Wourms, 1972b). 
Entrance into diapause is associated with decreased metabolic rate, inhibition of the cell cycle 
and cell growth, cessation of morphological development, and increased tolerance of 
environmental stress (Meller et al., 2012; Podrabsky et al., 2016a; Podrabsky et al., 2016b; 
Podrabsky and Hand, 1999). In A. limnaeus, survival of the dry season is likely due to arrest in 
diapause II, which occurs about midway through development after completion of 
somitogenesis but just prior to the major phases of organogenesis (Podrabsky et al., 2001; 
Podrabsky and Hand, 1999).  
Under laboratory conditions, typically more than 80% of A. limnaeus embryos enter 
into diapause II (Podrabsky et al., 2010), and early studies considered entrance into diapause 
as the default developmental pathway (Wourms, 1972a; Wourms, 1972b). Embryos that do 
not enter diapause II develop directly to diapause III, and were considered to “escape” 
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diapause by Wourms; thus embryos that do not enter diapause II are termed escape embryos 
(Wourms, 1972b). Subsequent studies have detailed that entrance into diapause II is an 
alternative pathway that differs morphologically and physiologically from direct developing 
escape embryos in all annual killifishes (Furness et al., 2015; Podrabsky et al., 2010). Under 
laboratory conditions and incubation of embryos at 25°C, young females are known to 
produce a higher proportion of escape embryos, while older females produce almost 
exclusively diapausing embryos (Podrabsky et al., 2010). However, the incubation 
temperatures experienced by the embryos can override maternal programming. Regardless 
of female age, incubation at 20°C results in 100% diapausing embryos, while incubation at 
30°C results in 100% escape embryos (Podrabsky et al., 2010). Temperature transfer 
experiments have established a “critical window” for this effect of temperature during 
somitogenesis in embryos possessing between 10 and 20 pairs of somites (Podrabsky et al., 
2010). Escape embryos have the potential to complete their entire lifespan within a single 
rainy season, rather than enduring the harsh conditions imposed by the dry season. This 
ecological trade-off has clear implications for survival of an individual and survival of the 
species. Thus, the pathways that regulate these developmental decisions are likely to be 
under intense selection pressure.  
In vertebrates, insulin-like growth factors are small protein hormones (~7.6 kDa) 
excreted via exocytosis into the extracellular space where they act as autocrine, paracrine, or 
endocrine signals (Lowe, 1991). Growth hormone signaling in adult tissues typically stimulates 
IGF transcription, translation, and excretion (Carter et al., 2002; Salvatori, 2004). In larvae and 
adults, hepatic (liver) cells are the primary producers of IGFs while a small amount is produced 
in a variety of other tissues. However, in embryonic tissues, IGFs are produced globally—
meaning various cells with different lineages will produce IGFs throughout the entire embryo 
(Allan et al., 2001; Dupont and Holzenberger, 2003; Greene and Chen, 1997; Lowe, 1991). 
 IGF proteins and their associated signaling pathways are highly conserved across 
vertebrates (Kenyon, 2001). The IGF family includes IGF-I and IGF-II proteins, and both of 
these proteins have been shown to regulate various aspects of development in invertebrate 
and vertebrate embryos (Dupont and Holzenberger, 2003). Increased IGF signaling is almost 
always associated with increased cell growth, proliferation, and differentiation in a variety of 
vertebrates including humans, birds and fish (de Pablo et al., 1993; Eivers et al., 2004; 
Furstenberger and Senn, 2002; Kajimura et al., 2005; Kamei et al., 2011; Oldham and Hafen, 
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2003; Salvatori, 2004). In mice, IGF-II null mutants grew to only 60% of normal birth weight 
and IGF-II(-/-)IGF-I(-/-) double mutants suffered further depression of growth reaching only 
30% of normal birth weight (Liu et al., 1993). In addition to their crucial role in regulating 
developmental growth, IGFs are also important differentiation factors and have been shown 
to induce differentiation in mice skeletal muscle and myoblast cell lines via autocrine and 
paracrine signaling (Tollefsen et al., 1989a; Tollefsen et al., 1989b).  
IGF activity is mitigated through three classes of receptors in vertebrates: insulin 
receptors, insulin-like growth factor I receptor (IGF1R), and insulin-like growth factor II 
receptor (IGF2R, or cation-independent mannose-6-phosphate receptor) (LeRoith et al., 1995; 
Nissley et al., 1991). IGF1R is the main receptor for IGF-I and IGF-II proteins that activates IGF 
signaling in response to binding. Insulin receptor (IR) has a much higher affinity for insulin 
than it does for IGF-II and IGF-I doesn’t react with IR homodimers, and thus IR is likely not 
physiologically active in terms of IGF signaling (Kim and Accili, 2002; Massague and Czech, 
1982). However, there is evidence of hybrid heterodimer formation by IR and IGF1R subunits 
(Kasuya et al., 1993; Soos et al., 1993) and these hybrid IR/IGF1R complexes have a high 
affinity for IGF-I rather than insulin, and behave like IGF1R receptors rather than IR receptors 
(Belfiore et al., 1999) . The activation of IGF1R results in a context dependent regulation of a 
diversity of cellular functions including metabolism, growth, proliferation, survival, 
transcription and protein synthesis (Jones and Clemmons, 2013; Vincent and Feldman, 2002). 
Loss of IGF receptor signaling during development leads to reduced growth. For example, Liu 
et al. (1993) showed that mutant mice that lacked IGF1R (IGF1R -/-), grew to only 45% of 
normal birth weight compared to wildtype. In contrast to the other receptors, IGF2R is a 
negative regulator of the IGF pathway and acts to attenuate IGF-II signals by stimulating 
endocytotic lysosomal degradation of IGF-II protein (Griffiths et al., 1988; Lau et al., 1994). 
Cellular metabolism, growth, and proliferation are severely downregulated in most 
organisms that arrest development (Hand et al., 2016). The mechanisms responsible for 
developmental arrest are not completely understood in any species, but a wealth of evidence 
points to the central importance of IGF signaling in regulating entrance into metabolic 
dormancy. For example, it has been shown in Caenorhabditis elegans nematodes that 
downregulation of DAF-2 (the C. elegans homolog of IGF1R) plays a crucial role in regulating 
entrance into dormancy as “dauer” larvae (Kimura et al., 1997). The IGF signaling pathway in 
C. elegans shares many similarities with vertebrate IGF signaling. Activation of DAF-2 leads to 
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phosphorylation of multiple substrates; one major target of activation is AKT1/2, which can 
affect many subsequent pathways. Active AKT suppresses the action of proteins such as DAF-
16 (FOXO homolog), which leads to increased protein synthesis and cell growth (Fielenbach 
and Antebi, 2008; Kimura et al., 1997; Pierce et al., 2001). Additionally, AKT activates 
pathways that lead to increased glucose metabolism, cell growth and survival, mobility, and 
blocks pathways that activate apoptosis. However, when larvae sense reduced food 
availability, IGF signaling is downregulated, which allows for increased activity of DAF-16 due 
to reduced activity of AKT and other regulatory proteins in the pathway (Lin et al., 2001; Ogg 
and Ruvkun, 1998). Thus, DAF-16 appears to be the major effector protein that induces the 
physiological phenotype associated with dauer formation (Hesp et al., 2015; Lin et al., 2001). 
In addition, FOXO has been shown to be a regulator of diapause in the mosquito Culex pipiens 
and Drosophila melanogaster (Puig et al., 2003; Sim and Denlinger, 2008). A number of lines 
of evidence suggest that downregulation of IGF signaling and the resulting upregulation of 
FOXO activity can induce conditions that reduce metabolic rate and protect an organism 
during times of environmental stress such as anoxia or starvation (Sim et al., 2015). 
Insulin-like growth factors are known to play major roles in the regulation of 
developmental growth and differentiation and have been implicated in the regulation of 
diapause-like states in other organisms. This study reports on the relative abundance of IGF-I 
and -II proteins during development and differentiation of two alternative developmental 
trajectories in A. limnaeus, escape embryos and embryos arresting in diapause II. Additionally, 
pharmacological inhibition of IGF1R mediated signaling during development is explored to 
test for a functional role for IGF signaling in the induction of diapause. Evidence is presented 
that implicates blockage of IGF signaling as an essential part of the program that induces 
diapause in embryos of A. limnaeus. 
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Materials and Methods 
 
Animal Care and Embryo Collection 
Detailed methods for the husbandry of adults and collection of embryos for 
Austrofundulus limnaeus (Quisiro strain) have been previously established (Podrabsky, 1999). 
This work was conducted under protocols reviewed and approved by the PSU Institutional 
Animal Care and Use Committee (PSU Protocol numbers 16 & 33). Briefly, spawning pairs of 
fish were housed in 10 l glass aquaria connected to a common sump system with biological, 
chemical and mechanical filtration. Ten percent of the system water (Portland City tapwater 
with 1 ppt Coralife sea salt) was changed twice daily. Temperature of the water was regulated 
at 26 ± 1 °C and photoperiod was set at 14L:10D. Fish were fed twice daily with frozen 
chironomid larvae (Hikari USA) or chopped earthworms. 
Embryos (collected twice weekly) were incubated in plastic culture dishes containing 
embryo medium as described in Podrabsky (1999). For temperature incubation experiments, 
embryos were transferred to 25˚C or 30˚C immediately after collection. Embryos were 
inspected and staged (WS = Wourms’ Stage) every 1-2 d according to Wourms (1972a) using 
an inverted microscope. Embryos used for protein quantification were flash-frozen 
individually in liquid nitrogen and stored at -80˚C. A total of 880 embryos were observed from 
two spawning events. 
To compare potential differences in maternal provisioning of IGFs in embryos bound 
to develop along the escape or diapause trajectories, 1-2 cell-stage embryos were sampled 
from females proven to be producing 100% diapausing or escape embryos as evidenced by 
following the developmental trajectory of a subset of each clutch of embryos. Only clutches 
of embryos that resulted in 100% diapause or 100% escape embryos were used to represent 
embryos maternally programmed for the diapause or escape trajectories. 
 
Protein extraction and quantification 
Individual embryos were homogenized on ice with an acrylic pellet pestle in 1.7 ml 
microcentrifuge tubes in 50 µl of 1X phosphate buffered saline (PBS) containing 1 µl of 
protease inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, Missouri, USA). The homogenate 
was subjected to centrifugation at 100 x g for 30 s at 4˚C to pellet large chunks of chorion. 
Homogenates were stored at -20˚C prior to protein analysis. On the day the ELISAs were run, 
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protein concentrations were determined using the Pierce MicroBCA protein assay kit 
according to the manufacturer’s instructions. 
 
Quantification of insulin-like growth factor I 
Relative concentrations of IGF-I were determined using an indirect enzyme-linked 
immunosorbent assay (ELISA). The validity of the assay was established by illustrating IGF-I 
protein standard and sample serial dilution collinearity and by confirming that the primary 
antibody only recognizes a single protein band of the correct molecular mass on a Western 
Blot (Figure S1). Samples and standards were run in triplicate. Standard curves for the assays 
were generated by serial dilution of a 1 mg ml-1 stock solution of IGF-I protein (Oncorhynchus 
mykiss, Lot FJI-AE01, Gropep, Adelaide, Australia) in carbonate buffer (15 mmol l-1 Na2CO3, 35 
mmol l-1 NaHCO3, pH 9.6) to a range of 1000 – 1 µg ml-1. Embryo homogenates were diluted 
to a total protein concentration of 5000 µg ml-1 in carbonate buffer. All washes and 
incubations were performed on a rocker with gentle rotation at room temperature unless 
otherwise noted. Solutions were removed from wells by pounding the microplate onto clean 
paper towels until the wells were dry unless otherwise noted. Wells of 96 well plates (flat 
bottom, polystyrene, Microlon® 200, med. binding, Greiner Bio-one, Germany) were coated 
with 100 µl of standards or samples for 24 h at 4˚C followed by 5 washes with 300 µl of 0.05% 
Tween-20 in 1X PBS for 5 min each. Wells were then blocked with 200 µl of 2% bovine serum 
albumin (BSA) in 1X PBS for 1 h at RT followed by 5 washes as described above. Wells were 
then incubated with 100 µl of IGF-I rabbit polyclonal antibody (anti-human IGF-I, Lot CJI-PAB-
GA, 1:1000 diluted, Gropep, Adelaide, Australia) for 1 h followed by 5 washes. Wells were 
then incubated with 100 µl of goat anti-rabbit IgG antibody conjugated with HRP (Lot 
ab97051, diluted 1:500, Abcam, Eugene, USA) for 1.5 h. Wells were again washed 5 times. 
Color development was initiated by the addition of 100 µl of 1-Step Ultra TMB-ELISA substrate 
(Thermofisher Scientific) followed by 15 min incubation at RT in the dark. Color development 
was stopped by the addition of 100 µl of 500 mmol l-1 sulfuric acid. Absorbance at 450 nm 
(A450) was measured using an Infinite M200 Pro microplate reader (Tecan, Männedorf, 
Switzerland). For each sample the average of three replicate values was used in subsequent 
calculations. Replicates were only used if they were within 20% of the sample mean. If a 
sample had less than 3 replicates within 20% of the mean, then the sample was re-run on a 
fresh plate from start to finish. 
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Quantification of insulin-like growth factor II 
The relative concentrations of IGF-II proteins were determined using a competitive 
binding enzyme-linked immunosorbent assay (ELISA) modified from (Wilkinson et al., 2004). 
The validity of the assay was established by illustrating IGF-II protein standard and sample 
serial dilution resulted in parallel changes in absorbance and by confirming that the primary 
antibody only recognizes a single protein band of the correct molecular mass on a Western 
Blot (Figure S1). Standards and samples were prepared in triplicate in 1.5 ml centrifuge tubes 
(Natural Micro Centrifuge Tube, Sealrite, USA Scientific). Standard solutions of purified 
salmon IGF-II (Lot CAG-AT01, GroPep, Adelaide, Australia) were diluted to final concentrations 
ranging from 1000 – 1 µg ml-1 in 1X PBS containing 0.1% BSA in a final volume of 400 µl. For 
embryo homogenates, 125 µg of total protein was diluted in 1X PBS containing 0.1% BSA to a 
final concentration of 5000 µg ml-1 in a final volume of 400 µl. Samples and standards were 
acidified by the addition of 70 µl 100 mmol l-1 Glycine-HCl (pH 2.0) followed by a 30 min 
incubation. The samples/standards were neutralized by the addition of 30 µl 200 mmol l-1 Tris 
(pH 10.0) followed by a 2 h incubation with IGF-II antibody solution (rabbit polyclonal anti-
trout IGF-II, Lot CA6-PAAA1, 1:3500 dilution, GroPep, Adelaide, Australia). 
Wells of 96 well microplates (flat bottom, polystyrene, Microlon® 200, med. Binding, 
Greiner Bio-one, Germany) were coated with 100 µl of a 50 µg ml-1 IGF-II protein solution 
diluted in carbonate buffer (see above) for 24 h at 4˚C. Coating buffer was removed and wells 
were then washed and blocked as described above for the IGF-I ELISA. After blocking, wells 
were washed again as described above followed by a 30 min incubation with 100 µl of IGF-II 
standards or embryo homogenates (prepared as described in the above paragraph). ELISA 
color development was essentially identical to the methods described above for the IGF-I 
assay except that the anti-rabbit IgG antibody conjugated with HRP was diluted 1:1000 and 
incubation time in this antibody was reduced to 1 hr. 
 
Pharmacological inhibition of insulin-like growth factor signaling 
All pharmacological agents were purchased from Selleck Chemicals (Houston, Texas, 
USA). Two inhibitors of IGF receptors were used. BMS-754807 is a specific inhibitor for IGF1R 
(Bid et al., 2013; Carboni et al., 2009), while NVP-AEW541 is a more general inhibitor of the 
insulin and IGF pathways due to inhibition of the kinase activity of those receptors (Garcıá-
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Echeverrıá et al., 2004). In addition, inhibitors of signaling molecules that are often 
downstream of IGF1R activation were used as well. LY294002 is an inhibitor of 
phosphoinositide 3-kinase (PI3K) activity, a common enzyme implicated in growth factor 
signal transduction (Vlahos et al., 1994). U0126 inhibits the activity of Mek1/2 proteins, which 
are key components of the MAP kinase signaling cascade (Duncia et al., 1998). Embryos of A. 
limnaeus are known to be highly impermeable to exogenous substances, and thus higher than 
expected external concentrations and dimethyl sulfoxide (DMSO) in the medium are required 
to achieve biologically active concentrations within the embryos (Podrabsky and Hand, 2000; 
Pri-Tal et al., 2011). Lyophilized pharmacological agents were reconstituted in 100% DMSO 
stock solutions that were diluted into embryo medium (Podrabsky, 1999) without antibiotics. 
For each inhibitor, control embryos were exposed to the same amount of DMSO as embryos 
treated with the pharmacological agents; the final concentration of DMSO was always less 
than 1%. Final concentrations used in the experiments were: NVP-AEW541 (100, 50, 20, 10, 
and 5 µmol l-1); BMS-754807 (5, 4, 3, 2.5, and 1 µmol l-1); Ly294002 (100, 50, 25, 5, and 2.5 
µmol l-1); U0126 (200, 100, and 50 µmol l-1). Preliminary range-finding experiments were used 
to determine these concentrations that are about 10 times the effective concentration used 
in similar experiments with BMS-754807 in embryos of the zebrafish, Danio rerio (Kamei et 
al., 2011).  
At 24 h post-fertilization, individual embryos were transferred to wells of a 96 well 
plate, each well containing 300 µl of embryo medium containing one of the four 
pharmacological inhibitors. Embryos were incubated continuously in the inhibitors at either 
25 or 30°C, and were observed daily and staged according to (Wourms, 1972a) using an 
inverted microscope. Heart rate in beats min-1 (as soon as heart contractions were visible) 
was monitored at RT (23-25°C) for embryos exposed to three concentrations of BMS-754807 
(2.5, 3 and 4 µmol l-1). In addition, the number of somite pairs was counted for each embryo. 
 
Statistical Analysis 
Graphical and statistical analyses were performed using Prism 7.0 software 
(GraphPad, La Jolla, CA, USA) and R version 3.2.1 (R Studio, https://www.rstudio.com). Where 
appropriate, analysis of variance (ANOVA), t-tests, or linear regression analyses were used. 
Tukey’s honest significant difference (HSD) or Dunnett’s test were used for post-hoc 
comparisons where appropriate. Statistical significance was always determined at a level of 
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P-value < 0.05. Relative abundance was calculated based on protein levels in 1-2 cell-stage 
embryos (WS 4).  
 
 
 
Results 
 
Pharmacological Inhibitors 
Embryos incubated in low concentrations of the Insulin and IGF1R receptors inhibitor 
(NVP-AEW541), and inhibitors of downstream signaling proteins involved in growth factor 
signaling (LY294002, U0126) had developmental rates that were indistinguishable from 
control embryos incubated at 30˚C (data not shown). In contrast, medium and high dosages 
of these pharmacological agents resulted in 80-100% death (data not shown). Those embryos 
that did survive exhibited severe developmental malformation. These data are interpreted to 
be the result of broad and non-specific effects caused by blocking signaling pathways that are 
indispensable for normal development and are discussed no further.  
 
Inhibition of IGF1R 
BMS-754807, a potent inhibitor of IGF1R, exhibited specific effects on development 
that were dosage-dependent. The rate at which embryos progress through development was 
significantly retarded by increasing concentrations of inhibitor (Figure 1). Compared to 
embryos developing at 30˚C along the escape trajectory, embryos incubated at 30˚C in 
inhibitor concentrations of 2.5 µmol l-1 and greater were delayed significantly (ANOVA, 
Tukey’s HSD, P < 0.01). Embryos developing in intermediate concentrations of inhibitor (2.5, 
3 and 4 µmol l-1) that were incubated at 30˚C developed at rates indistinguishable from 
control embryos developing at 25˚C (ANOVA and Tukey’s HSD, P = 1.0, 1.0, 0.07, respectively). 
The 5 µmol l-1 treatment group was significantly delayed compared to all other treatments, 
and embryos never progressed past the dispersed cell phases of development to establish a 
neural keel (Figure 1). Rates of somitogenesis (Figure 2) were significantly reduced by 
incubation in the IGF1R inhibitor. Linear regression analysis (of the linear portion of the curve) 
indicates that control embryos developing at 30˚C added somites at a rate of 7.5 ± 0.7 (mean 
± SD) somite pairs per day, while control embryos at 25˚C and embryos treated with 
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inhibitor at 30˚C all had significantly lower rates (regression analysis, comparison of slopes; 
P < 0.001) of somitogenesis that ranged from 3.1-3.6 somite pairs per day (25˚C = 3.1 ± 0.1, 
2.5 µmol l-1 = 3.1 ±0.2, 3 µmol l-1 = 3.6 ± 0.1, 4 µmol l-1 = 3.3 ± 0.2). Regression analysis 
comparing the slopes for 25˚C control embryos and those treated with inhibitor indicated no 
statistically significant differences in the slopes of these treatment groups (P = 0.3). Further, 
heart rate was significantly decreased in embryos incubated at 30˚C in the presence of the 
IGF1R inhibitor (Figure 3). In fact, for embryos incubated at 2.5, 3, and 4 µmol l-1 BMS-754807, 
heart rates were similar to embryos incubated at 25˚C along the diapause trajectory (ANOVA 
and Tukey’s HSD, P = 0.3, 1.0, and 1.0, respectively).  
Embryos incubated in 5 µmol l-1 BMS-754807 arrested development in the dispersion 
and reaggregation (D/R) phases of development. Embryos treated with 2.5, 3, and 4 µmol l-1 
BMS-754807 developed a morphology very similar to those of diapause II embryos with some 
significant differences (Figure 4). First, melanocytes differentiate and migrate in embryos 
exposed to inhibitor concentrations up to 3 µmol l-1, however the 4 µmol l-1 treatment group 
did not develop melanocytes. Melanocytes never differentiate until after diapause II in 
normal embryos. Second, despite the low heart rates, circulating blood cells that express 
hemoglobin were observed in the embryos treated with all levels of inhibitor that allowed 
development past the D/R stages. Again, expression of hemoglobin does not normally 
develop until post-diapause II development. Otherwise, the general morphology and number 
of somite pairs are quite similar to those of diapause II embryos (Figure 4). 
 
Abundance of IGF-I 
When similar stage embryos are compared, there is a clear spike in IGF-I protein 
abundance between WS 20 and WS 30 in embryos developing at 30°C along the escape 
trajectory (Figure 5). Abundance increases almost 6-fold by WS 23 (reaggregating 
blastomeres), remains high through WS 28 (solid neural keel), and then returns to levels 
similar to those at fertilization at WS 30 (10 somite embryo) (ANOVA, Dunnett’s MCT, P < 
0.001). Abundance of IGF-I in embryos developing at 25°C does not increase above levels 
present at fertilization until after embryos exit diapause II at WS 40 and later (ANOVA, 
Dunnett’s MCT, P < 0.0001). Thus, embryos incubated at 30°C experience a spike in IGF-I 
protein abundance early in development that is completely absent in embryos developing at 
25°C (Figure 5). The pattern of IGF-I protein abundance during late development (WS 32 – 43) 
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is also very different in the two developmental trajectories. Escape embryo (30°C) IGF-I levels 
peak at WS 37, long before growth and development are complete, and then decrease to 
levels that are indistinguishable from WS 4 embryos at WS 43. In contrast, post-diapause II 
embryos (25°C) reach peak abundance of IGF-I at WS 43, essentially at the completion of 
development. These different patterns of abundance are supported by statistical differences 
in mean IGF-I protein levels at numerous developmental stages (Figure 5). 
 
Abundance of IGF-II 
The pattern of IGF-II abundance is quite different from that of IGF-I, for both 
developmental trajectories. First, in contrast to IGF-I levels embryos collected from females 
that were confirmed to be producing 100% escape embryos produced embryos with 
significantly higher levels of IGF-II protein at fertilization (Figure 5, WS 4 comparison). Second, 
there was a significant decrease in IGF-II protein levels during early development in both 
developmental trajectories. Statistically significant increases in IGF-II protein abundance are 
not observed until late embryonic development in both trajectories.  
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Discussion 
 
Insulin-like growth factors are known to be critical for proper cell growth and 
differentiation during vertebrate development (de Pablo et al., 1993; Dupont and 
Holzenberger, 2003; Eivers et al., 2004; Richard-Parpaillon et al., 2002). In addition, IGFs have 
been shown to play a critical role in the regulation of metabolic dormancy associated with 
diapause or diapause-like states in a number of organisms (Fielenbach and Antebi, 2008; 
Hondo and Stewart, 2004; Kimura et al., 1997; Ogg and Ruvkun, 1998; Sim and Denlinger, 
2013; Sim et al., 2015). This is the first study to evaluate the potential role of IGFs in 
development and diapause in embryos of the annual killifish Austrofundulus limnaeus. 
 
Maternal provisioning and promotion of the escape trajectory 
Maternal provisioning or influences are known to affect the developmental trajectory 
of A. limnaeus (Podrabsky et al., 2010). IGF-I protein levels were not differentially provisioned 
into embryos bound for either developmental trajectory. However, the higher abundance of 
IGF-II protein in 1-2 cell-stage embryos of A. limnaeus that are presumed to be developing 
along the escape trajectory may indicate a role for IGF-II in the regulation of maternal control 
over developmental trajectory. Indeed, the paternal IGF-II gene is imprinted in many species 
(DeChiara et al., 1991; O'Dell and Day, 1998; Vu and Hoffman, 1994) and thus there is 
precedent for regulation of IGF-II levels being important for normal development. The data 
presented in this study suggest a possible role for this differential packaging in determining 
developmental trajectory, but many future studies would be needed to test this hypothesis. 
 
IGF signaling and entrance into diapause II  
Inhibition of IGF1R signaling resulted in developmental and physiological phenotypes 
that approximate the diapause trajectory even under environmental conditions that should 
promote development along the escape trajectory. These similarities between embryos 
incubated at 30˚C in the presence of inhibitors and those incubated at 25˚C are striking and 
suggest a critical role for IGF signaling in promoting the escape trajectory in annual killifish. 
The lack of a significant increase in IGF-I or IGF-II protein levels until post-diapause II 
development in embryos incubated at 25˚C compared to the early and sustained expression 
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of IGF-I in embryos at 30˚C both support a role for reduced IGF-I signaling in the promotion 
of the diapause II phenotype. 
Somitogenesis is a highly regulated patterning of the paraxial (somatic) mesoderm 
next to the developing neural tube. Once initiated, this process proceeds according to a highly 
stereotyped addition of somite pairs in an anterior to posterior pattern (Pourquie, 2001). The 
highly similar pattern and rate of somite development in embryos treated with IGF1R 
inhibitors compared to control embryos destined to enter diapause II suggests that the rate 
of this process is likely regulated by muted IGF signaling under developmental conditions that 
favor the diapause II trajectory. In fact, for embryos developing at 25˚C levels of IGF-I and IGF-
II protein do not increase above amounts present at fertilization until after diapause II is 
broken further supporting a role for muted IGF signaling in the promotion of diapause in this 
species. 
Insulin-like growth factor signaling is crucial for normal cardiac and circulatory 
development in vertebrates. Zebrafish, Danio rerio, embryos with reduced IGF binding 
protein-2, which increases the half-life of IGFs and has been shown to mediate binding of 
IGF1R (Jones and Clemmons, 2013), had reduced amounts of IGF-I mRNA, reduced body 
growth, and disruptions to cardiovascular development (Wood et al., 2005). More recently 
IGF-II expression was found to be crucial for supporting increased cellular proliferation in 
primary mouse embryonic epicardial cells (Li et al., 2011). Thus, the delay in the development 
of cardiac activity observed in this study is also consistent with a role for reduced IGF signaling 
in determining the diapause phenotype.  
Despite the above observations that suggest a critical role for IGF signaling in 
determining the diapause II phenotype, there were some key differences in phenotype 
between inhibited embryos and those that naturally enter diapause II. The pre-diapause II 
development of melanocytes and expression of hemoglobin are two notable differences. It is 
important to note that these differences are likely due to the difficulty of completely 
inhibiting IGF signaling through the use of pharmacological inhibitors, and indeed the results 
presented here suggest that different processes may require different thresholds of IGF 
activity, or may work through alternative signaling routes.  
Under normal conditions, melanocytes do not develop in embryos of A. limnaeus until 
after diapause II. In contrast, embryos developing in the presence of inhibitor exhibited 
differentiation and migration of melanocytes in all but the highest two concentrations of 
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inhibitor. Melanocytes are derived from neural crest cells that migrate away from the 
developing neural tube and differentiate into a variety of embryonic structures – many or 
perhaps all of which are critical features of the vertebrate body plan. IGF-II is one of the signals 
that can rapidly induce neural crest cells to undergo an epithelium to mesenchyme transition, 
the first step in migrating away from the neural tube (Morali et al., 2001). Thus, there is reason 
to believe that IGF signaling may have an effect on melanocyte development, and indeed 
embryos exposed to the highest level of inhibitor that allowed development past D/R failed 
to develop melanocytes prior to arresting development in a diapause II-like stage. 
Blood cell differentiation and proliferation is known to be regulated by IGF signaling, 
and many blood cancers exhibit increased levels of IGF signaling (Bertrand et al., 2006). Thus, 
it is not surprising that conditions that increase levels of IGF-I protein (incubation at 30˚C) 
would accelerate development of differentiated red blood cells expressing hemoglobin. The 
inability to block this process with the inhibitor may indicate an especially strong effect of IGF 
signaling on blood cell differentiation, or it may indicate the use of alternative receptors that 
are not as sensitive to the inhibitor (e.g. insulin-IGF1R heterodimers).  
 
IGF signaling as a potential link between dispersion/reaggregation and diapause 
 Previous studies indicate that incubation of embryos at 30°C leads to 100% of the 
embryos developing along the escape trajectory (Podrabsky et al., 2010). In addition, a 
“critical window” of developmental time in embryos between 10 and 20 somites was 
identified when temperature appears to exert irreversible effects on developmental 
trajectory. Interestingly, the spike in IGF-I protein levels in escape embryos occurs just prior 
to the critical developmental window. This spike in protein levels is likely important for 
supporting the completion of the D/R of the blastomeres, as embryos with the highest levels 
of IGF1R inhibitor were unable to develop past this point in development, and a small (not 
statistically significant) increase in IGF-I protein was observed during this phase of 
development in control embryos developing at 25°C. Thus, it is possible that reduced IGF 
signaling is critical for determining developmental patterns associated with both D/R and 
diapause II. In fact, others have suggested that the D/R process is simply an extensive 
prolongation of a normally very short part of teleost development (Berois et al., 2012). If this 
is the case, the data presented here are consistent with reduced IGF signaling playing a key 
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role in this unique aspect of annual killifish development as well. The ability to enter into 
diapause and the developmental pattern that includes D/R always co-occur in annual 
killifishes, and this paper represents the first potential mechanism for the co-evolution of 
these two traits through a common mechanism. 
 
Catch-up growth during post-diapause II development 
Compensatory acceleration in growth and development is a common reaction in 
animals following release from stressed states or adverse environments that have slowed or 
arrested growth. This phenomenon is called “catch-up” growth and is found in embryos from 
a variety of animals, and in response to a number of human diseases (Fielenbach and Antebi, 
2008; Gillooly et al., 2002; Hales and Ozanne, 2003; Kajimura et al., 2005; Saenger et al., 
2007). In D. rerio embryos, compensatory growth after release from hypoxia-induced growth 
arrest was confirmed to be fueled by over-expression of IGF-I (Kamei et al., 2011). The broad 
phylogenetic representation of catch-up growth suggests that the phenomenon is likely an 
important and evolutionarily conserved mechanism with adaptive value. Patterns of 
metabolic enzyme activity measured during post-diapause II development in A. limnaeus 
suggest catch-up growth is a normal part of development for this species. This observation is 
based on the rate of increase in lactate dehydrogenase (LDH) and citrate synthase (CS) activity 
in embryos developing post-diapause II at 25°C and those developing at 25 and 30°C along 
the escape trajectory (Chennault and Podrabsky, 2010). The slope of the increase in activity 
for both of these enzymes associated with post-diapause II development at 25°C was 
equivalent to the embryos developing at 30°C, suggesting an acceleration in the rate that 
overcame the expected decrease associated with the differences in temperature (Chennault 
and Podrabsky, 2010). Patterns of IGF-I and IGF-II abundance in the present study support a 
role for increased abundance of IGFs fueling this compensatory acceleration in the rate of 
development. For example, both IGF-I and IGF-II increase dramatically late in development in 
post-diapause II embryos. In contrast, escape embryos reach a peak in abundance for both 
proteins much earlier in development. Thus, post-diapause II embryos complete development 
with higher levels of IGF-I and IGF-II. The long term consequences of this pattern are 
unknown, but the documented differences in adult physiology and reproductive fitness that 
are associated with these two developmental trajectories in other species of annual killifishes 
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suggest that these developmental differences in IGF expression may have profound 
consequences on the biology of these fish (Polačik et al., 2014). In other systems, long-term 
effects have been noted. For example, in rats, Rattus rattus, male longevity was reduced in 
individuals that experienced developmental retardation and subsequent “catch-up” growth 
compared to those developing along a more continuous trajectory (Hales and Ozanne, 2003).  
 
Conclusions 
 This study provides evidence that blocking of IGF signaling plays a critical role in the 
arrest of growth and differentiation observed as A. limnaeus embryos enter into diapause. 
There are striking similarities between embryos entering into diapause naturally, and the 
patterns of growth arrest and physiological development that are induced by treatment with 
a potent inhibitor of IGF1R. Further, patterns of IGF protein abundance during development 
suggest a relationship between IGF signaling and many aspects of the unique life history of 
annual killifishes including the occurrence of the dispersion and reaggregation phases of 
development, and differences in aging characteristics of adults that follow distinct 
developmental trajectories. This study is the first to present experimental evidence that 
blocking IGF signaling is important for promotion of diapause in annual killifishes, and that 
this mechanism may explain the many unique life history characteristics of annual killifishes. 
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Figure 1. Developmental progression of embryos incubated at 30˚C exposed to a range of 
concentrations of the IGF1R inhibitor BMS-754807. Increasing concentrations of the inhibitor 
significantly retard rate of development. At inhibitor levels of 2.5, 3, and 4 µmol l-1, 
developmental progression in embryos at 30˚C indistinguishable from those developing at 
25˚C (ANOVA and Tukey’s HSD, p-value = 1.0, 1.0, 0.07, respectively). Symbols are means ± 
sem (n = 10 individual embryos). 
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Figure 2. Rates of somitogenesis in embryos incubated at 30˚C and treated with the IGF1R 
inhibitor BMS-754807. Linear regression analysis indicates that embryos treated with 
inhibitor and incubated at 30˚C had rates of somitogenesis that were comparable to embryos 
incubated at 25˚C (see text for details). Data for the DMSO controls and 30˚C escape embryos 
were combined, because regression analysis indicated no significant differences (p = 1.0). 
Symbols are means ± sem (n = 5-13 individual embryos). 
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Figure 3. Heart rate in embryos incubated at 30˚C in the presence of the IGF1R inhibitor 
BMS-754807. Treated embryos had heart rates comparable to embryos developing at 25˚C 
along the diapause trajectory. (ANOVA and Tukey’s HSD, p = 0.3, 1.0, and 1.0, respectively). 
Control embryos incubated at 30˚C have heart rates significantly higher than all other 
treatments (ANOVA, Tukey’s HSD p < 0.0001). Symbols are means ± sem (n = 1-10 individual 
embryos). 
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Figure 4. Images of embryos incubated at 30˚C and treated with the IGF1R inhibitor BMS-
754807. Embryos were observed over 32 days post-treatment (dpt). All groups were initially 
exposed to inhibitor at WS 10-12 (blastula stage) at 1 d post-fertilization and were 
continuously exposed for the duration of development. Embryos incubated at 2.5, 3, and 4 
µmol l-1 inhibitor developed in a manner very similar to embryos incubated at 25˚C along the 
diapause trajectory. 
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Figure 5. Relative abundance of IGF-I and IGF-II protein in embryos incubated at 25°C 
(diapause II trajectory) and 30°C (escape trajectory) as a function of developmental stage. 
Protein levels are expressed relative to the mean of protein levels for embryos at Wourms’ 
stage (WS) 4 (0 days post-fertilization) incubated at 25°C. Symbols are means ± sem (n=3-10 
individual embryos). Black dotted lines at y=1 indicate relative expression level of WS 4 
embryos. Gray vertical dashed lines indicate various developmental stages as indicated in the 
top panel. The gray shaded area represents the critical window for temperature to effect 
developmental trajectory (Podrabsky et al., 2010). Statistical comparisons were made within 
each treatment group only using ANOVA and Dunnett’s multiple comparison test (see text for 
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details). Symbols with an asterisk are statistically different from levels at WS 4 for each 
treatment group (P < 0.01). Pound symbols indicate statistical differences between the two 
developmental trajectories, at those developmental stages where data were available for 
both (two-way ANOVA, Sidak’s Multiple Comparison test, P < 0.001). For IGF-I protein levels 
at WS 4, there were no differences found between embryos developing on either trajectory, 
and thus these data were combined.  For IGF-II there were significant differences at WS 4 for 
the two trajectories and the escape embryos are represented by the filled purple circles. 
 
 
 
Jo
ur
na
l o
f E
xp
er
im
en
ta
l B
io
lo
gy
 •
 A
dv
an
ce
 a
rt
ic
le
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.1
0.2
0.3
0.4
Dilution
A
45
0
Standards
Sample
A
0.001 0.01 0.1
0.0
0.5
1.0
1.5
Dilution
A
45
0
C
Sample
Standards
B
D
IGF-I
IGF-II
ConMW BL AL
ConMW BL AL
Figure S1. Validation of ELISA assays 
for detection and quantification of 
relative levels of IGF proteins in 
Austrofundulus limnaeus. (A) Serial 
dilutions of an IGF-I protein standard and 
an A. limnaeus liver sample exhibit 
colinearity in the IGF-I indirect ELISA 
assay. The slopes of the lines are not 
statistically different (Regression 
analysis, P = 0.32). (B) Western blot 
analysis indicates the IGF-I antibody 
used detects only a single band at just 
under 10 kDa in A. limnaeus liver 
samples that co-migrates with a purified 
IGF-I protein standard. (C) Serial 
dilutions of an IGF-II protein standard 
and an A. limnaeus liver sample change 
in parallel in the IGF-II competitive 
binding ELISA assay. Nonlinear 
regression analysis supported a single 
regression equation to best describe 
both sigmoidal curves (r2 = 0.99). (D) 
Western blot analysis indicates the IGF-II 
antibody used detects only a single band 
at just under 10 kDa in A. limnaeus liver 
samples that co-migrates with a purified 
IGF-II protein standard. MW = molecular 
mass markers, Con = IGF protein 
control, BL = blank lane, AL = A. 
limnaeus liver sample.
Western Blot Methods
Liver was extracted from a young adult male and the sample was prepared as described for the ELISA assays. Lanes 
were loaded with 20 µg of liver protein and 5 µg of IGF protein (see Materials and Methods for specifics on the 
standards). Proteins were separated on a 12 % SDS-PAGE gel (150 V for 90 min). Proteins were transferred to a 
PVDF membrane (130 V for 90 min). Membranes were washed 3 times with TNT buffer (0.1 M Tris, 150 mM NaCl, 
0.1 % (v/v) Tween-20) for 5 min each. Membranes were blocked with 10 % nonfat milk in TNT buffer for 30 min, 
followed by 3 washes in TNT buffer for 5 min each. Membranes were exposed to the same primary antibodies used 
in the ELISA assays for 12 h at RT. (anti-human IGF-I, 1:1000 diluted, Lot CJI-PAB-GA; anti-trout IGF-II, 1:500 
diluted, Lot CA6-PAAA1. Both antibodies from GroPep, Adelaide, Australia). The membranes were washed 3 times 
with TNT buffer for 5 min prior to exposure to a 90 min incubation in secondary antibody (Goat, anti-rabbit-HRP, 
diluted 1:10,000, Lot ab97051, Abcam, Eugene, USA). The membranes were then washed with TNT buffer 3 times 
for 5 min. Antigen binding was determined by enhanced chemiluminescence (Pierce™ ECL Western Blotting 
Substrate, Catalog #32106, Lot # RJ239671A, Thermo Fischer Scientific, Waltham, USA) and luminescence was 
detected using a digital imager (Fluorochem SP system, Alpha Innotech, San Leandro, USA).
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